Th17 cells are long lived and retain a stem cell-like molecular signature

Muranski, Pawel, Borman, Zachary A., Kerkar, Sid P., Klebanoff, Christopher A., Ji, Yun, Sanchez-Perez, Luis, Sukumar, Madhusudhanan, Reger, Robert N. +14 more·2011·Immunity
DOI 10.1016/j.immuni.2011.09.019

Cited by (441)

Items 101–200 of 441

  1. New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
    Vanessa Sue Wacleche, Jean-Philippe Goulet, Annie Gosselin, Patricia Monteiro, Hugo Soudeyns, Rémi Fromentin, Mohammad-Ali Jenabian, Shant M. Vartanian, Steven G. Deeks, Nicolas Chomont et al. · 2016 · Retrovirology
  2. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy
    Hong Sun, Dhohyung Kim, Xiaodong Li, Maja Kiselinova, Zhengyu Ouyang, Linos Vandekerckhove, Hong Shang, Eric S. Rosenberg, Xu G. Yu, Mathias D. Lichterfeld · 2015 · Journal of Virology
  3. Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice
    Lili Chen, Xinyu Zhou, Yawei Wang, Dake Wang, Yueshuang Ke, Xianlu Zeng · 2021 · Molecular Nutrition & Food Research
  4. CD103+ Dendritic Cells Control Th17 Cell Function in the Lung
    Zelante, Teresa, Wong, Alicia Yoke Wei, Ping, Tang Jing, Chen, Jinmiao, Sumatoh, Hermi R., Viganò, Elena, Hong Bing, Yu, Lee, Bernett, Zolezzi, Francesca, Fric, Jan et al. · 2015 · Cell Reports
  5. Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
    François Martin, Lionel Apétoh, François Ghiringhelli · 2012 · Trends in Molecular Medicine
  6. Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy
    Zhi‐Chun Ding, Lei Huang, Bruce R. Blazar, Hideo Yagita∥, Andrew L. Mellor, David H. Munn, Gang Zhou · 2012 · Blood
  7. Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse
    Saad S. Kenderian, David L. Porter, Saar I. Gill · 2016 · Transplantation and Cellular Therapy
  8. Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma
    Yoshiko Takeuchi, Atsushi Tanemura, Yasuko Tada, Ichiro Katayama, Atsushi Kumanogoh, Hiroyoshi Nishikawa · 2017 · International Immunology
  9. T Follicular Helper Cell Heterogeneity
    Wenzhi Song, Joseph E. Craft · 2023 · Annual Review of Immunology
  10. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T <sub>H</sub> 1 and T <sub>H</sub> 9 cells
    Benoit-Lizon, Isis, Jacquin, Elise, Rivera Vargas, Thaiz, Richard, Corentin, Roussey, Aurélie, Dal Zuffo, Ludivine, Martin, Tiffany, Melis, Andréa, Vinokurova, Daria, Shahoei, Sayyed Hamed et al. · 2022 · Journal for ImmunoTherapy of Cancer
  11. PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
    Jacob S. Bowers, Kinga Majchrzak, Michelle Hase Nelson, Bülent Arman Aksoy, Megan M. Wyatt, Aubrey S. Smith, Stefanie R. Bailey, Lillian R. Neal, Jeff Hammerbacher, Chrystal Mary Paulos · 2017 · Frontiers in Immunology
  12. Beyond T cell exhaustion: TIM-3 regulation of myeloid cells
    Karen Olivia Dixon, Gonzalo Fernandez Lahore, Vijay Kumar Kuchroo · 2024 · Science Immunology
  13. Increased Circulating Th17 Cells after Transarterial Chemoembolization Correlate with Improved Survival in Stage III Hepatocellular Carcinoma: A Prospective Study
    Yuan Liao, Bo Wang, Zhi-Liang Huang, Ming Shi, Xing‐Juan Yu, Limin Zheng, Shengping Li, Lian Li · 2013 · PLoS ONE
  14. IL‐27 enhances the survival of tumor antigen‐specific CD8+ T cells and programs them into IL‐10‐producing, memory precursor‐like effector cells
    Zhenzhen Liu, Jin‐Qing Liu, Fatemeh Talebian, Lai‐Chu Wu, Shulin Li, Xue‐Feng Bai · 2012 · European Journal of Immunology
  15. Identity crisis of Th17 cells: many forms, many functions, many questions
    Sundrud, Mark S., Trivigno, Catherine · 2013 · Seminars in Immunology
  16. TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
    André Kunert, Trudy Straetemans, Coen Govers, Cor Lamers, Ron H.J. Mathijssen, Stefan Sleijfer, Reno Debets · 2013 · Frontiers in Immunology
  17. Effector γδ T Cell Differentiation Relies on Master but Not Auxiliary Th Cell Transcription Factors
    Joana Barros‐Martins, Nina Schmolka, Diana Fontinha, Marta Pires de Miranda, J. Pedro Simas, Ingrid C. Brok, Cristina Ferreira, Marc Veldhoen, Bruno Silva‐Santos, Karine Serre · 2016 · The Journal of Immunology
  18. Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis
    Luigi Franchi, Ivan Monteleone, Ling-Yang Hao, Mark A. Spahr, Wenpu Zhao, Xikui Liu, Kellie M. Demock, Aditi Kulkarni, Charles A. Lesch, Brian Sanchez et al. · 2017 · The Journal of Immunology
  19. Th17 cell pathogenicity in autoimmune disease
    Park, Eunchong, Ciofani, Maria · 2025 · Experimental &amp; Molecular Medicine
  20. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy
    Gabriela Khoury, Jenny L. Anderson, Rémi Fromentin, Wendy Hartogenesis, Miranda Z. Smith, Peter Bacchetti, Frederick M. Hecht, Nicolas Chomont, Paul U. Cameron, Steven G. Deeks et al. · 2016 · AIDS
  21. Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy
    Chen Chen, Feng‐Hou Gao · 2019 · Frontiers in Immunology
  22. Relationship between Th17 immune response and cancer
    Hanna Santos Marques, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Maria Luísa Cordeiro Santos, Júlio César Braga de Souza, Thiago Macêdo Lopes Correia, Luana Weber Lopes, Nayara Silva de Macêdo Neres, Rafael Santos Dantas Miranda Dórea, Anna Carolina Saúde Dantas et al. · 2021 · World Journal of Clinical Oncology
  23. MHC class II restricted neoantigen: A promising target in tumor immunotherapy
    Zhichen Sun, Fangjun Chen, Fanyan Meng, Jia Wei, Baorui Liu · 2017 · Cancer Letters
  24. Autoimmunity in dry eye disease – An updated review of evidence on effector and memory Th17 cells in disease pathogenicity
    Yihe Chen, Reza Dana · 2021 · Autoimmunity Reviews
  25. Harnessing the Microbiome to Enhance Cancer Immunotherapy
    Michelle Hase Nelson, Marshall A. Diven, Logan W. Huff, Chrystal Mary Paulos · 2015 · Journal of Immunology Research
  26. Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
    Devalingam Mahalingam, Judy Sing-Zan Wang, Erika Paige Hamilton, John Sarantopoulos, John J. Nemunaitis, Garry Alan Weems, Laura Carter, Xiao Hu, Marshall T. Schreeder, H. Jeffrey Wilkins · 2019 · Clinical Cancer Research
  27. Smart CARs engineered for cancer immunotherapy
    Saul J. Priceman, Stephen J. Forman, Christine E. Brown · 2015 · Current Opinion in Oncology
  28. The Role of CD4 T Cell Help in CD8 T Cell Differentiation and Function During Chronic Infection and Cancer
    Paytsar Topchyan, Siying Lin, Weiguo Cui · 2023 · Immune Network
  29. Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
    Gabriel Arellano, Eric Acuña, Lilian I. Reyes, Payton A. Ottum, Patrizia De Sarno, Luis Antonio Villarroel, Ethel Ciampi, Reinaldo Uribe‐San Martín, Claudia Cárcamo, Rodrigo Fernandes Naves · 2017 · Frontiers in Immunology
  30. HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
    Rémi Fromentin, Nicolas Chomont · 2020 · Seminars in Immunology
  31. LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy
    Delphine Planas, Amélie Pagliuzza, Rosalie Ponte, Augustine Fert, Laurence Raymond Marchand, Marta Massanella, Annie Gosselin, Vikram Mehraj, Franck P. Dupuy, Stéphane Isnard et al. · 2021 · EBioMedicine
  32. Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations
    Guinevere Q. Lee, Mathias D. Lichterfeld · 2016 · Current Opinion in HIV and AIDS
  33. Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
    Milad Taghizadeh-Anvar, Kimiya Rashidan, Nima Arsam, Ashkan Rasouli‐Saravani, Hamidreza Yadegari, Ali Ahmadi, Zeynab Asgari, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad, Safa Tahmasebi · 2024 · Cancer Cell International
  34. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
    Jacob S. Bowers, Michelle Hase Nelson, Kinga Majchrzak, Stefanie R. Bailey, Bärbel Rohrer, Andrew Kaiser, Carl Atkinson, Luca Gattinoni, Chrystal Mary Paulos · 2017 · JCI Insight
  35. TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways
    Yuxue Jiang, Jintong Chen, Enguang Bi, Yinghua Zhao, Tianxue Qin, Yiming Wang, Alison Wang, Sujun Gao, Qing Yi, Siqing Wang · 2019 · Journal for ImmunoTherapy of Cancer
  36. NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
    Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci, Vincenzo Gianluca Messana, Nadia Raffaelli, Silvia Deaglio · 2019 · Frontiers in Immunology
  37. miR‐148a is upregulated by Twist1 and T‐bet and promotes Th1‐cell survival by regulating the proapoptotic gene Bim
    Claudia Haftmann, Anna‐Barbara Stittrich, Jakob Zimmermann, Zhuo Fang, Kristyna Hradilkova, Markus Bardua, Kerstin Westendorf, Gitta Anne Heinz, René Riedel, Julia Siede et al. · 2014 · European Journal of Immunology
  38. LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity
    Yanyan Wang, Xingrong Du, Jun Wei, Lingyun Long, Haiyan Tan, Cliff S. Guy, Yogesh Dhungana, Chenxi Qian, Geoffrey A. M. Neale, Yang‐Xin Fu et al. · 2019 · Cell Research
  39. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells
    Gang Xue, Ningbo Zheng, Jing Fang, Guangxu Jin, Xiaoyin Li, Gianpietro Dotti, Qing Yi, Yong Lu · 2021 · Cancer Cell
  40. Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective
    Alaleh Rezalotfi, Elmira Ahmadian, Hossein Aazami, Ghasem Solgi, Marzieh Ebrahimi · 2019 · Frontiers in Oncology
  41. Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
    David Andreu-Sanz, Sebastian Kobold · 2023 · Cancers
  42. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth
    Enrique Martín‐Gayo, Jacqueline Cronin, Taylor L. Hickman, Zhengyu Ouyang, Madelene Lindqvist, Kellie E. Kolb, Julian Schulze zur Wiesch, Rafael A. Cubas, Filippos Porichis, Alex K. Shalek et al. · 2017 · JCI Insight
  43. Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs
    Constance Renault, Nicolas Veyrenche, Franck J. D. Mennechet, Anne‐Sophie Bedin, Jean‐Pierre Routy, Philippe Van de Perre, Jacques Reynes, Édouard Tuaillon · 2022 · Frontiers in Immunology
  44. Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
    Esther Schoutrop, Thomas Poiret, Ibrahim El Serafi, Ying Heng Zhao, Rui He, Alina Moter, Johan Henriksson, Moustapha Hassan, Isabelle Magalhaes, Jonas Mattsson · 2023 · Journal for ImmunoTherapy of Cancer
  45. Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
    Elisabetta Volpe, Luca Battistini, Giovanna Borsellino · 2015 · Mediators of Inflammation
  46. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo
    Xiao Hu, Kinga Majchrzak, Xikui Liu, Megan M. Wyatt, Chauncey J. Spooner, Jacques Moisan, Weiping Zou, Laura Carter, Chrystal Mary Paulos · 2018 · Cancer Research
  47. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients
    Marwa Bsat, Laurence Chapuy, Manuel Rubio, Ramsès Wassef, Carole S. Richard, Frank Schwenter, Rasmy Loungnarath, Geneviève Soucy, Heena Mehta, Marika Sarfati · 2019 · Frontiers in Immunology
  48. Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression
    Pedro Augusto Carvalho Costa, Walison Nunes da Silva, Pedro Henrique Dias Moura Prazeres, Caroline C. Picoli, Gabriela D. A. Guardia, Alinne C. Costa, Mariana de Almeida Oliveira, Pedro Pires Goulart Guimarães, Ricardo Gonçalves, Mauro Cunha Xavier Pinto et al. · 2021 · Acta Neuropathologica Communications
  49. Optimizing the manufacturing and antitumour response of CAR T therapy
    Yutong Liu, Adam Samuel Sperling, Eric L. Smith, David J. Mooney · 2023 · Nature Reviews Bioengineering
  50. T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
    Xiaoxia Chi, Shahang Luo, Peng Ye, Wei‐Lun Hwang, Jong‐Ho Cha, Xiuwen Yan, Wenhao Yang · 2023 · Frontiers in Immunology
  51. Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles
    Sejin Son, Jutaek Nam, April S. Kim, Jinsung Ahn, Kyung Soo Park, May Thazin Phoo, Brett Sherren, Weiping Zou, Soo‐Hong Lee, Omid Cameron Farokhzad et al. · 2022 · Nature Biomedical Engineering
  52. Divergent CD4+ T Memory Stem Cell Dynamics in Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections
    Emily Kathleen Cartwright, Colleen S. McGary, Barbara Cervasi, Luca Micci, Benton Lawson, Sarah T. C. Elliott, Ronald G. Collman, Steven E. Bosinger, Mirko Paiardini, Thomas H. Vanderford et al. · 2014 · The Journal of Immunology
  53. Identification of novel HIV-1 dependency factors in primary CCR4+CCR6+Th17 cells via a genome-wide transcriptional approach
    Aurélie Cleret‐Buhot, Yuwei Zhang, Delphine Planas, Jean-Philippe Goulet, Patricia Monteiro, Annie Gosselin, Vanessa Sue Wacleche, Cecile L. Tremblay, Mohammad-Ali Jenabian, Jean‐Pierre Routy et al. · 2015 · Retrovirology
  54. TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
    Jonas Byström, Felix I. L. Clanchy, T.E.I. Taher, Pam K. Mangat, Ali S. Jawad, Richard O. Williams, Rizgar A. Mageed · 2016 · Cytokine
  55. The outstanding antitumor capacity of CD4+ T helper lymphocytes
    Tong Li, Bowen Wu, Tao Yang, Long Zhang, Ke Jin · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  56. Highly polarized T h17 cells induce EAE via a T ‐bet independent mechanism
    Heather M. Grifka‐Walk, Stephen J. Lalor, Benjamin M. Segal · 2013 · European Journal of Immunology
  57. Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
    Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, Jin Hyang Song, Myroslawa Soloshchenko, Jianing Fu, Stefanie R. Bailey, Chenthamarakshan Vasu, Andrew S. Kraft, Chrystal Mary Paulos et al. · 2014 · Cancer Research
  58. Differentiation of distinct long-lived memory CD4 T cells in intestinal tissues after oral Listeria monocytogenes infection
    Pablo Alberto Romagnoli, Han‐Hsuan Fu, Zhijuan Qiu, Camille F Khairallah, Q.M. Pham, Lynn Puddington, Kamal Mohan Khanna, Leo Lefrançois, Brian S. Sheridan · 2016 · Mucosal Immunology
  59. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity
    Yihe Chen, Sunil K. Chauhan, Xuhua Tan, Reza Dana · 2016 · Journal of Autoimmunity
  60. Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment?
    Shane Crotty · 2017 · Cold Spring Harbor Perspectives in Biology
  61. The role of Th17 immunity in chronic ocular surface disorders
    Nai‐Wen Fan, Thomas H. Dohlman, William Foulsham, Matthew J. McSoley, Rohan Bir Singh, Yihe Chen, Reza Dana · 2020 · The Ocular Surface
  62. SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth
    Hélène Berger, Frédérique Végran, Madijd Chikh, Federica Gilardi, Sylvain Ladoire, Hélène Bugaut, Grégoire Mignot, Fanny Chalmin, Mélanie Bruchard, Valentin Dérangère et al. · 2013 · Cancer Research
  63. Immunopathology alters Th17 cell glucocorticoid sensitivity
    Jesus Banuelos, Y. Cao, Soon Cheon Shin, Nick Z. Lu · 2016 · Allergy
  64. Memory T cell subsets in tuberculosis: What should we be targeting?
    Marcela I. Henao-Tamayo, Diane J. Ordway, Ian M. Orme · 2014 · Tuberculosis
  65. Novel immunotherapies for hematologic malignancies
    Michelle Hase Nelson, Chrystal Mary Paulos · 2014 · Immunological Reviews
  66. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
    David F. Stroncek, Carolina Berger, Martin A. Cheever, Richard W. Childs, Mark E. Dudley, Peter Flynn, Luca Gattinoni, James R. Heath, Michael D. Kalos, Francesco Maria Marincola et al. · 2012 · Journal of Translational Medicine
  67. The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies.
    Lillian R. Neal, Stefanie R. Bailey, Megan M. Wyatt, Jacob S. Bowers, Kinga Majchrzak, Michelle Hase Nelson, Carl Haupt, Chrystal Mary Paulos, Juan C Varela · 2017 · PubMed
  68. RORγt expression in mature T H 17 cells safeguards their lineage specification by inhibiting conversion to T H 2 cells
    Xinxin Chi, Wei Jin, Xiaohong Zhao, Tian Xie, Jing Shao, Xue Bai, Yu Jiang, Xiaohu Wang, Chen Dong · 2022 · Science Advances
  69. T Memory Stem Cells and HIV: a Long-Term Relationship
    Ann Chahroudi, Guido Silvestri, Mathias D. Lichterfeld · 2015 · Current HIV/AIDS Reports
  70. CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells
    Katarina Stanko, Christina Iwert, Christine Appelt, Katrin Vogt, Julia Schumann, Franziska Janina Strunk, Stefanie Ahrlich, Stephan Schlickeiser, Chiara Romagnani, Karsten Jürchott et al. · 2018 · Proceedings of the National Academy of Sciences
  71. The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer
    Darya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier · 2013 · Clinical and Developmental Immunology
  72. Writ large: Genomic dissection of the effect of cellular environment on immune response
    Nir Yosef, Aviv Regev · 2016 · Science
  73. A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
    Adeliane Castro da Costa, Abadio de Oliveira Costa-Júnior, Fábio Muniz de Oliveira, Sarah Veloso Nogueira, Joseane Damaceno Rosa, Danilo Pires Resende, André Kipnis, Ana Paula Junqueira‐Kipnis · 2014 · PLoS ONE
  74. Th17 cells have stem cell-like features and promote long-term immunity
    Shuang Wei, Ende Zhao, Ilona Kryczek, Weiping Zou · 2012 · OncoImmunology
  75. Identification of human CD4 + T cell populations with distinct antitumor activity
    Michelle Hase Nelson, Hannah M. Knochelmann, Stefanie R. Bailey, Logan W. Huff, Jacob S. Bowers, Kinga Majchrzak, Megan M. Wyatt, Mark P. Rubinstein, Shikhar Mehrotra, Michael I. Nishimura et al. · 2020 · Science Advances
  76. Molecular Mechanisms of T Helper Cell Differentiation and Functional Specialization
    Gap Ryol Lee · 2023 · Immune Network
  77. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease
    Wei Li, Liangyi Liu, Aurélie Gomez, Jilu Zhang, Abdulraouf M. Ramadan, Qing Zhang, Sung Won Choi, Peng Zhang, Joel K. Greenson, Chen Liu et al. · 2016 · JCI Insight
  78. Immunological considerations in the development of Pseudomonas aeruginosa vaccines
    Sarah M. Baker, James B. McLachlan, Lisa A. Morici · 2019 · Human Vaccines & Immunotherapeutics
  79. Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy
    Yin Qianmei, Zehong Su, Guang Wang, Hui Li, Gaojian Lian · 2021 · Immunologic Research
  80. Vaccine immunity against fungal infections
    Som Gowda Nanjappa, Bruce S. Klein · 2014 · Current Opinion in Immunology
  81. The role of T helper 17 and regulatory T cells in tumor microenvironment
    Soheil Najafi, Abbas Mirshafiey · 2019 · Immunopharmacology and Immunotoxicology
  82. A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin
    Malika Davids, Anil Pooran, Clemens Hermann, Lynelle Mottay, Fawziyah Thompson, Jacob Cardenas, Jing-hua Gu, Thearith Koeuth, Richard Meldau, Jason D. Limberis et al. · 2019 · American Journal of Respiratory and Critical Care Medicine
  83. Human ectonucleotidase-expressing CD25 high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions
    Marion Thibaudin, Marie Chaix, Romain Boidot, Frédérique Végran, Valentin Dérangère, Emeric Limagne, Hélène Berger, Sylvain Ladoire, Lionel Apétoh, François Ghiringhelli · 2015 · OncoImmunology
  84. Foxo transcription factors in T cell biology and tumor immunity
    Luo, Chong T., Li, Ming O. · 2018 · Seminars in Cancer Biology
  85. The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells
    Matthias Lochner, Zuobai Wang, Tim D. Sparwasser · 2015 · Progress in molecular biology and translational science
  86. Development and Function of Protective and Pathologic Memory CD4 T Cells
    Shafqat Ahrar Jaigirdar, Megan K. L. MacLeod · 2015 · Frontiers in Immunology
  87. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic
    Kinga Majchrzak, Michelle Hase Nelson, Stefanie R. Bailey, Jacob S. Bowers, Xue‐Zhong Yu, Mark P. Rubinstein, Richard A. Himes, Chrystal Mary Paulos · 2016 · Cancer Immunology Immunotherapy
  88. Targeting the IL-9 pathway in cancer immunotherapy
    Ningbo Zheng, Yong Lu · 2020 · Human Vaccines & Immunotherapeutics
  89. T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance
    Xin Gao, Kaiming Luo, Diya Wang, Yunbo Wei, Yin Yao, Jun Deng, Yang Yang, Qunxiong Zeng, Xiaoru Dong, Le Xiong et al. · 2023 · eLife
  90. STAT3 Role in T-Cell Memory Formation
    Yaroslav Kaminskiy, Jan Joseph Melenhorst · 2022 · International Journal of Molecular Sciences
  91. HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities
    Sonia Moretti, Ivan Schietroma, Giuseppe Sberna, Maria Teresa Maggiorella, Leonardo Sernicola, Stefania Farcomeni, Marta Giovanetti, Massimo Ciccozzi, Alessândra Borsetti · 2023 · International Journal of Molecular Sciences
  92. Development of a unique epigenetic signature during in vivo Th17 differentiation
    Bi-Huei Yang, Stefan Floess, Stefanie Hagemann, Igor V. Deyneko, Lothar Groebe, Joern Pezoldt, Tim D. Sparwasser, Matthias Lochner, Jochen Huehn · 2015 · Nucleic Acids Research
  93. Transcription Factor Networks Directing the Development, Function, and Evolution of Innate Lymphoid Effectors
    Joonsoo Kang, Nidhi Malhotra · 2015 · Annual Review of Immunology
  94. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
    Kinga Majchrzak, Michelle Hase Nelson, Jacob S. Bowers, Stefanie R. Bailey, Megan M. Wyatt, John M. Wrangle, Mark P. Rubinstein, Juan Carlos Varela, Zihai Li, Richard A. Himes et al. · 2017 · JCI Insight
  95. The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue
    Michelle Hase Nelson, Sreenath Kundimi, Jacob S. Bowers, C.E. Rogers, Logan W. Huff, Kristina M. Schwartz, Krishnamurthy Thyagarajan, Elizabeth C. Little, Shikhar Mehrotra, David J. Cole et al. · 2015 · The Journal of Immunology
  96. Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells
    Nasr Y. A. Hemdan · 2012 · Immunology Letters
  97. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy
    Yohei Kawai, Ai Kawana‐Tachikawa, Shuichi Kitayama, Tatsuki Ueda, Shoji Miki, Akira Watanabe, Shin Kaneko · 2021 · Molecular Therapy
  98. Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells
    Scott N. Furlan, Benjamin K. Watkins, Victor Tkachev, Sarah Cooley, Angela Panoskaltsis‐Mortari, Kayla Betz, Melanie Brown, Daniel J. Hunt, John B. Schell, Katie Zeleski et al. · 2016 · Blood
  99. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
    Anusara Daenthanasanmak, Yongxia Wu, Supinya Iamsawat, Hung Dang Nguyen, David A Bastian, Meng-Meng Zhang, Mohammed Hanief Sofi, Shilpak Chatterjee, Elizabeth Goodwin Hill, Shikhar Mehrotra et al. · 2018 · Journal of Clinical Investigation
  100. Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
    Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra, Besim Öğretmen · 2021 · Scientific Reports